Opportunity Information: Apply for PAR 20 143
The National Institutes of Health (NIH) funding opportunity titled "Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional)" (Funding Opportunity Number PAR-20-143) supports research aimed at reducing firearm-related injuries and deaths in the United States. The program is grounded in the public health burden of firearm harm, noting that nearly 40,000 people in the U.S. die each year from firearm-related causes, with the majority of deaths resulting from suicide (about 60 percent) and a large share from homicide (about 37 percent). Beyond fatalities, the opportunity highlights the significant number of people who survive firearm injuries, including injuries that are intentional (such as assaults) and unintentional (such as accidental shootings). In response to Congressional direction in the FY2020 Further Consolidated Appropriations Act (H.R. 1865), NIH is taking a broad, evidence-focused approach to understanding why firearm injuries occur and what strategies can prevent them, including approaches relevant to crime prevention, while operating within NIH policy and statutory limits described in notices such as NOT-OD-20-068 and NOT-OD-20-066.
The core purpose of the grant is to strengthen the science around firearm injury and mortality prevention by supporting studies that clarify the determinants and drivers of firearm injury, improve methods for identifying people at risk (including both potential victims and potential perpetrators), and develop and test interventions that could reduce injuries and deaths. This includes both creating new, innovative prevention approaches and improving the real-world use of interventions that already have evidence behind them. A key emphasis is not only on whether an intervention can work under ideal conditions, but also how to implement effective strategies more consistently and successfully in practical settings such as health systems, schools, community organizations, or other service environments where prevention efforts often take place.
This is a discretionary grant program under the NIH, and it falls within broad federal activity categories that include education, health, income security, and social services. Multiple CFDA listings are associated with the opportunity (93.213, 93.273, 93.279, 93.307, 93.865, 93.866), reflecting the cross-cutting nature of NIH institutes and centers that may support related research. The mechanism is an R61, and the listing specifies "Clinical Trial Optional," meaning applicants may propose clinical trials if appropriate, but they are not required to do so. The posted award ceiling is $400,000. The original closing date listed for the opportunity was 2020-05-15, and the opportunity record indicates a creation date of 2020-03-20.
Eligibility is broad and intentionally inclusive to encourage participation from many types of organizations that can contribute to firearm injury prevention research. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofit organizations both with and without 501(c)(3) status (as long as they are not institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The opportunity also explicitly calls out additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
At the same time, the solicitation places firm limits on foreign involvement. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply, and foreign components as defined in the NIH Grants Policy Statement are not allowed. In practice, that means applications must be led and carried out by eligible U.S.-based organizations without foreign organizational components participating in the ways NIH defines as a foreign component under its policy framework.Apply for PAR 20 143
- The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.273, 93.279, 93.307, 93.865, 93.866.
- This funding opportunity was created on 2020-03-20.
- Applicants must submit their applications by 2020-05-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this NIH grant?
The opportunity is titled "Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional)" and the Funding Opportunity Number is PAR-20-143.
What is the overall goal of this funding opportunity?
The goal is to strengthen the science around preventing firearm-related injuries and deaths in the United States by supporting research that explains why firearm injuries occur and identifies strategies that can prevent them.
What public health problem is this program addressing?
The opportunity is grounded in the public health burden of firearm harm in the U.S., citing that nearly 40,000 people die each year from firearm-related causes. It also highlights that many people survive firearm injuries, including both intentional injuries (such as assaults) and unintentional injuries (such as accidental shootings).
Does the opportunity describe the major causes of firearm-related deaths?
Yes. It notes that the majority of firearm-related deaths are from suicide (about 60 percent) and a large share are from homicide (about 37 percent).
What kinds of research topics does NIH want to support under this program?
Supported research areas include studies that (1) clarify determinants and drivers of firearm injury, (2) improve methods to identify people at risk (including potential victims and potential perpetrators), and (3) develop and test interventions that could reduce firearm injuries and deaths.
Is the focus only on creating new interventions?
No. The opportunity includes both developing new, innovative prevention approaches and improving the real-world use of interventions that already have evidence supporting them.
Does the program emphasize real-world implementation?
Yes. A key emphasis is understanding not only whether an intervention can work under ideal conditions, but also how to implement effective strategies more consistently and successfully in practical settings.
What examples of practical settings are mentioned for implementing prevention strategies?
The opportunity mentions settings such as health systems, schools, community organizations, and other service environments where prevention efforts often take place.
What is the grant mechanism for this opportunity?
The mechanism is an NIH R61.
What does "Clinical Trial Optional" mean for this opportunity?
"Clinical Trial Optional" means applicants may propose clinical trials if appropriate, but they are not required to include a clinical trial.
What is the maximum award amount (award ceiling) listed?
The posted award ceiling is $400,000.
What type of program is this within the federal system?
It is a discretionary grant program under the National Institutes of Health (NIH).
Which broad federal activity categories are associated with this opportunity?
The opportunity is associated with broad activity categories that include education, health, income security, and social services.
Are there CFDA listings associated with this opportunity?
Yes. Multiple CFDA listings are associated with this opportunity: 93.213, 93.273, 93.279, 93.307, 93.865, and 93.866.
Why are multiple CFDA listings included?
The multiple CFDA listings reflect the cross-cutting nature of NIH institutes and centers that may support related firearm injury and mortality prevention research.
What prompted NIH to take this approach to firearm injury and mortality prevention research?
The opportunity references Congressional direction in the FY2020 Further Consolidated Appropriations Act (H.R. 1865), which led NIH to take a broad, evidence-focused approach to understanding firearm injuries and identifying prevention strategies.
Does the opportunity mention crime prevention?
Yes. It notes that NIH is taking an evidence-focused approach that includes approaches relevant to crime prevention, while operating within NIH policy and statutory limits.
Are there specific NIH notices mentioned that describe policy and statutory limits?
Yes. The opportunity references NIH notices such as NOT-OD-20-068 and NOT-OD-20-066 in relation to operating within NIH policy and statutory limits.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations, including various levels of government, educational institutions, tribal entities, nonprofits, and businesses, as described in the opportunity.
Are state, local, and tribal governments eligible?
Yes. Eligible applicants include state governments, county governments, city or township governments, special district governments, federally recognized Native American tribal governments, and certain tribal organizations.
Are school districts and higher education institutions eligible?
Yes. Eligible applicants include independent school districts, public and state-controlled institutions of higher education, and private institutions of higher education.
Are nonprofit organizations eligible?
Yes. Eligible applicants include nonprofit organizations with 501(c)(3) status and nonprofit organizations without 501(c)(3) status, provided they are not institutions of higher education in those nonprofit categories.
Are for-profit organizations eligible?
Yes. Eligible applicants include for-profit organizations other than small businesses, as well as small businesses.
Are public housing authorities eligible?
Yes. The opportunity lists public housing authorities and Indian housing authorities as eligible applicants.
Are U.S. territories or possessions eligible?
Yes. The opportunity explicitly lists U.S. territories or possessions as eligible applicant types.
Are Historically Black Colleges and Universities (HBCUs) and other minority-serving institutions eligible?
Yes. The opportunity explicitly calls out eligibility for HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), and Tribally Controlled Colleges and Universities (TCCUs).
Are faith-based or community-based organizations eligible?
Yes. The opportunity explicitly includes faith-based or community-based organizations among the eligible applicant types.
Are eligible federal agencies allowed to apply?
Yes. The opportunity includes eligible federal agencies as an eligible applicant type.
Are non-U.S. (foreign) organizations eligible to apply?
No. Non-domestic (non-U.S.) entities are not eligible to apply.
Can a U.S. organization apply if it has a non-domestic component?
No. Non-domestic components of U.S. organizations are not eligible to apply under this opportunity.
Are foreign components allowed in the proposed project?
No. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
What does the restriction on foreign components mean in practical terms?
In practice, the application must be led and carried out by eligible U.S.-based organizations without foreign organizational components participating in ways NIH defines as a foreign component under its policy framework.
What was the original closing date listed for this opportunity record?
The original closing date listed was 2020-05-15.
What is the opportunity record creation date?
The opportunity record indicates a creation date of 2020-03-20.
Browse more opportunities from the same category: Education, Health, Income Security and Social Services
Next opportunity: Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)
Previous opportunity: U.S. Embassy Brussels PAS Annual Program Statement (APS)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 20 143
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 20 143) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) Apply for PA 20 176 Funding Number: PA 20 176 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required) Apply for PA 20 191 Funding Number: PA 20 191 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) Apply for PA 20 199 Funding Number: PA 20 199 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed) Apply for RFA EB 20 001 Funding Number: RFA EB 20 001 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $300,000 |
| Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) Apply for RFA OD 20 020 Funding Number: RFA OD 20 020 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) Apply for RFA OD 20 023 Funding Number: RFA OD 20 023 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $500,000 |
| Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) Apply for RFA OD 20 021 Funding Number: RFA OD 20 021 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed) Apply for RFA MH 20 556 Funding Number: RFA MH 20 556 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) Apply for RFA MH 20 620 Funding Number: RFA MH 20 620 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) Apply for RFA MH 21 140 Funding Number: RFA MH 21 140 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) Apply for RFA EY 21 001 Funding Number: RFA EY 21 001 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) Apply for PAR 21 144 Funding Number: PAR 21 144 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) Apply for PAR 21 145 Funding Number: PAR 21 145 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Firearm Injury and Mortality Prevention Research (R01Clinical Trial Optional) Apply for PAR 21 192 Funding Number: PAR 21 192 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Firearm Injury and Mortality Prevention Research (R21/R33 Clinical Trial Optional) Apply for PAR 21 191 Funding Number: PAR 21 191 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) Apply for RFA MH 21 135 Funding Number: RFA MH 21 135 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) Apply for PAR 21 163 Funding Number: PAR 21 163 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) Apply for RFA MH 21 130 Funding Number: RFA MH 21 130 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $300,000 |
| Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) Apply for PAR 21 162 Funding Number: PAR 21 162 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional) Apply for RFA AI 21 018 Funding Number: RFA AI 21 018 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 143", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.